Filing
Spy
Filing
Spy
Home
About
FDMT — 4d Molecular Therapeutics, Inc. - FilingSpy
FDMT
4d Molecular Therapeutics, Inc.
Clinical-stage gene therapy company
CUSIP: 35104E100
Healthcare
US
1 holder
Ownership
Activity
2022 Q4
7 of 15 quarters
Total Value
$87.46M
Total Shares
3.94M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$87.46M
3.94M
0.4%
Unchanged
Viking Global Investors
$87.46M
3.94M shares
Unchanged